Startup
MT
Metagen Therapeutics
メタジェンセラピューティクス株式会社
#62 in the Japan Top 100 Startups
| Founded / HQ | 2020 · Tsuruoka, Yamagata / Tokyo |
|---|---|
| Equity raised to date | ≥ ¥7.1B “累計調達額71億円以上” Company-stated cumulative · as of 25 Sept 2026 · Metagen Therapeutics (PR TIMES) Release does not state whether the cumulative includes grants. |
| Last round | 25 Sept 2026 · Series B extension · ¥300M 3億円 |
| Latest public valuation | Not publicly disclosed (we do not estimate) |
| Key investors | GLIN Impact Capital |
| Unicorn | No |
Funding rounds in 2026
Amounts are the full announced figure. Grey amounts aren't counted in equity totals. † includes debt, grants or other non-equity (hover for detail).
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 25 Sept 2026 | MTMetagen Therapeutics | Series B extension | ¥300M | GLIN Impact Capital | BiotechDeep tech |
| 4 Sept 2026 | MTMetagen Therapeutics | Series B extension (1st close) | ¥190M | 15th Rock | BiotechDeep tech |
| 26 Feb 2026 | MTMetagen Therapeutics | Series B | ¥3.5B | Canon Marketing Japan MIRAI FundMatsukiyoCocokara & CompanyMedipal Holdings | BiotechDeep tech |